Zobrazeno 1 - 10
of 1 313
pro vyhledávání: '"Masarova, L."'
Autor:
Masarova L; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Chifotides HT Dr; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Publikováno v:
Blood [Blood] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.
Autor:
Huang M; Department of Lymphoma/ Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Ke Z; Department of Lymphoma/ Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Lyu MA; Department of Lymphoma/ Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Masarova L; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Sadeghi T; Cellenkos Inc., Houston, TX, USA., Flowers CR; Department of Lymphoma/ Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Parmar S; Department of Lymphoma/ Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
IScience [iScience] 2024 Aug 27; Vol. 27 (9), pp. 110830. Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).
Autor:
Tefferi A; Mayo Clinic, Rochester, Minnesota, United States., Barosi G; IRCCS Policlinico S. Matteo, Pavia, Italy., Passamonti F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Hernandez-Boluda JC; Hospital Clínico Valencia, Valencia, Spain., Bose P; University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Döhner K; University Hospital of Ulm, Ulm, Germany., Ellis M; Meir Medical Center, Kfar Saba, Israel., Gangat N; Mayo Clinic, Rochester, Minnesota, United States., Garcia JS; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Gisslinger H; Medical University of Vienna, Vienna, Austria., Gotlib J; Stanford Cancer Institute, Stanford, California, United States., Guglielmelli P; Univ. of Florence and Azienda Ospedaliera Careggi, Florence, Italy., Gupta V; The Princess Margaret Cancer Centre, Toronto, Canada., Harrison CN; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Hexner EO; University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States., Hobbs GS; Massachusetts General Hospital, Boston, Massachusetts, United States., Kiladjian JJ; Hôpital Saint-Louis AP-HP & Université Paris Cité, Paris, France., Koschmieder S; RWTH Aachen University, Aachen, Germany., Kröger N; University Medical Center Hamburg_Eppendorf, Hamburg, Germany., Kuykendall AT; Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Loscocco GG; University of Florence, Florence, Italy., Mascarenhas JO; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Masarova L; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Mesa R; Wake Forest University School of Medicine, Charlotte, North Carolina, United States., Mora B; Division of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy., Odenike O; The University of Chicago, Chicago, Illinois, United States., Oh ST; Washington University School of Medicine, St. Louis, Missouri, United States., Pardanani AD; Mayo Clinic, Rochester, Minnesota, United States., Patel AA; University of Chicago, Chicago, Illinois, United States., Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Rambaldi A; Università degli Studi di Milano, Bergamo, Italy., Rampal RK; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Sirhan S; Jewish General Hospital- McGill University, Montreal, Quebec, Canada., Szuber N; University of Montreal, Montreal, Quebec, Canada., Talpaz M; University of Michigan, Ann Arbor, Michigan, United States., Vachhani P; O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama, United States., Vannucchi AM; Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Barbui T; FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, Italy.
Publikováno v:
Blood [Blood] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Autor:
Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carter BZ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nasnas C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nasr L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Skinner J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2024 Aug 01; Vol. 130 (15), pp. 2652-2659. Date of Electronic Publication: 2024 Apr 09.
Autor:
Bose P; The University of Texas MD Anderson Cancer Center. pbose@mdanderson.org., Masarova L; The University of Texas MD Anderson Cancer Center., Pemmaraju N; The University of Texas MD Anderson Cancer Center., Bledsoe SD; The University of Texas MD Anderson Cancer Center., Daver NG; The University of Texas MD Anderson Cancer Center., Jabbour EJ; The University of Texas MD Anderson Cancer Center., Kadia TM; The University of Texas MD Anderson Cancer Center., Estrov Z; The University of Texas MD Anderson Cancer Center., Kornblau SM; The University of Texas MD Anderson Cancer Center., Andreeff M; The University of Texas MD Anderson Cancer Center., Jain N; The University of Texas MD Anderson Cancer Center., Cortes JE; The University of Texas MD Anderson Cancer Center., Borthakur G; The University of Texas MD Anderson Cancer Center., Alvarado Y; The University of Texas MD Anderson Cancer Center., Richie MA; The University of Texas MD Anderson Cancer Center., Dobbins MH; The University of Texas MD Anderson Cancer Center., McCrackin SA; The University of Texas MD Anderson Cancer Center., Zhou L; The University of Texas MD Anderson Cancer Center., Pierce SA; The University of Texas MD Anderson Cancer Center., Wang X; The University of Texas MD Anderson Cancer Center., Pike AM; The University of Texas MD Anderson Cancer Center., Garcia-Manero G; The University of Texas MD Anderson Cancer Center., Kantarjian HM; The University of Texas MD Anderson Cancer Center., Verstovsek S; The University of Texas MD Anderson Cancer Center.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2660-2664. Date of Electronic Publication: 2024 Aug 01.
Autor:
Jen WY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2229-2232. Date of Electronic Publication: 2024 Aug 28.
Autor:
Masarova L; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA., Verstovsek S; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer, Houston, TX 77030, USA., Liu T; GSK plc, Philadelphia, PA 19104, USA., Rao S; GSK plc, Philadelphia, PA 19104, USA., Sajeev G; Analysis Group, Boston,MA 02199, USA., Fillbrunn M; Analysis Group, Boston,MA 02199, USA., Simpson R; Analysis Group, Boston,MA 02199, USA., Li W; Analysis Group, Boston,MA 02199, USA., Yang J; GSK plc, Philadelphia, PA 19104, USA., Lorier YL; GSK plc, Philadelphia, PA 19104, USA., Gorsh B; GSK plc, Philadelphia, PA 19104, USA., Signorovitch J; Analysis Group, Boston,MA 02199, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Jul 29, pp. 1-12. Date of Electronic Publication: 2024 Jul 29.
Autor:
Abuasab T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Villarreal J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1434-1436. Date of Electronic Publication: 2024 Apr 13.
Autor:
Goulart H; Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Masarova L; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Mesa R; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA., Harrison C; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kiladjian JJ; Hospital Saint-Louis, AP-HP, CIC 1427, Inserm, Université Paris Cité, Paris, France., Pemmaraju N; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 48-60. Date of Electronic Publication: 2024 Jun 10.
Autor:
Patel AB; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mesa RA; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, NC, USA., Hobbs G; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun 13, pp. 1-13. Date of Electronic Publication: 2024 Jun 13.